Stable gastric pentadecapeptide BPC 157 heals established vesicovaginal fistula and counteracts stone formation in rats
Plasma is removed through an IV and centrifuge with the goal of extricating harmful substances such as proteins that cause plaque build-up, autoimmune conditions, arthritis, and even neurodegenerative disorders such as Alzheimers disease
Biochemical Mechanisms of the Components BPC-157
Glutathione reduces oxidative stress, keeping inflammation at bay
Multiple clinical trials and controlled studies have demonstrated: Statistically significant improvements in skin firmness and elasticity with consistent use Reduction in fine lines and wrinkle depth over 3-6 months of application Improved skin density, moisture retention, and surface texture Reduction in photodamage and hyperpigmentation Tightening of loose skin documented in both topical and injectable applications Citation: Leyden JJ et al
The information presented here is for scientific reference purposes only and should not be construed as medical advice or guidance.